6 Einträge gefunden

1. Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer

   1. Kluth, Martina
   2. Meyer, David
   3. Krohn, Antje
   4. Freudenthaler, Fabian
   5. Bauer, Melanie
   6. Salomon, Georg
   7. Heinzer, Hans

   2016 - Forschungsinformationssystem des UKE
2. Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer

   1. Kluth, Martina
   2. Galal, Rami
   3. Krohn, Antje
   4. Weischenfeldt, Joachim
   5. Tsourlakis, Maria Christina
   6. Paustian, Lisa
   7. Ahrary, Ramin

   2015 - Forschungsinformationssystem des UKE
3. Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer

   1. Krohn, Antje
   2. Freudenthaler, Fabian
   3. Harasimowicz, Silvia
   4. Kluth, Martina
   5. Fuchs, Sarah
   6. Burkhardt, Lia
   7. Stahl, Phillip

   2014 - Forschungsinformationssystem des UKE
4. Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

   1. Kluth, Martina
   2. Harasimowicz, Silvia
   3. Burkhardt, Lia
   4. Grupp, Katharina
   5. Krohn, Antje
   6. Prien, Kristina
   7. Gjoni, Jovisa

   2014 - Forschungsinformationssystem des UKE
5. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

   1. Burkhardt, Lia
   2. Fuchs, Sarah
   3. Krohn, Antje
   4. Masser, Sawinee
   5. Mader, Malte
   6. Kluth, Martina
   7. Bachmann, Frederik

   2013 - Forschungsinformationssystem des UKE
6. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

   1. Kluth, Martina
   2. Hesse, Jana
   3. Heinl, Anna
   4. Krohn, Antje
   5. Steurer, Stefan
   6. Sirma, Hüseyin
   7. Simon, Ronald

   2013 - Forschungsinformationssystem des UKE